FAT3 and cancer: Compared with wild-type LUADs, patients in the FAT3+/LRP1B+ group were correlated with earlier cancer onset (median age 63.5 vs 67 years old, p=0.012), and the tumors were more commonly occurred in Black/African American (18.18% vs 8.30%, p=0.037).